Vijaya Diagnostic Centre Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹188Cr
- +20.5% YoY
- +8.7% QoQ
- Net profit
- ₹39Cr
- +21.9% YoY
- +11.4% QoQ
- Margin
- 39%
- 0 pp YoY
- −1 pp QoQ
Guidance rank: #28 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth. The company maintains a consistent revenue growth guidance of 15%+ annually, driven primarily by volume growth (~13%) and price increases (1.5%-2%).
From Vijaya Diagnostic Centre Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth.
- Price increases contribute approximately 1.5% to 2% of the revenue growth.
- Existing (old) centers are expected to continue growing test volumes by around 9%-10%.
- New centers contribute the remaining volume growth, with rapid ramp-up seen in newly entered markets like East India and Bangalore.
- The company aims to expand revenue in new geographies (e.g., East India) to Rs. 50-100 crore within 2-3 years through opening hubs and spokes.
- Growth is driven by market share gains, increased patient footfalls, and expansion into new regions.
2 more points from Vijaya Diagnostic Centre Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Vijaya Diagnostic Centre Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- For FY26, guided overall CAPEX for new centers is around Rs. 150-155 crores.
- Replacement CAPEX expected at 2%-3% of overall topline.
- Five new hubs have been commissioned in the current quarter; five more hubs planned for the next two quarters.
- Scouting for new locations across core and new geographies (including Bangalore, Kolkata, Pune) is ongoing.
2 more points from Vijaya Diagnostic Centre Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vijaya Diagnostic Centre Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Vijaya Diagnostic Centre Ltd said on order book & pipeline — free account, 30 seconds.
Vijaya Diagnostic Centre Ltd — Quarterly revenue & net profit
Vijaya Diagnostic Centre Ltd Q1 FY26 results — key figures
| ₹ Cr | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 188 | 156 | +20.5% | 173 | +8.7% |
| Operating profit (EBITDA) | 74 | 61 | +21.3% | 69 | +7.2% |
| Operating margin | 39% | 39% | 0 pp | 40% | -1 pp |
| Profit before tax | 52 | 42 | +23.8% | 47 | +10.6% |
| Net profit (PAT) | 39 | 32 | +21.9% | 35 | +11.4% |
| EPS (₹) | 3.76 | 3.06 | +22.9% | 3.40 | +10.6% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹255 Cr, net profit ₹59 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vijaya Diagnostic Centre's management said in earlier quarters
Others in Healthcare Services this season
- Aster DM Quality (Q1 FY26)
Recent quarters saw subdued volume growth due to leadership changes and seasonal effects, but an 8% volume growth was achieved in Q1 FY26, improving from 2% in…
- Dr Agarwal's Hea (Q1 FY26)
70 crores via preferential allotment to AEHL for CAPEX plans, particularly the flagship facility at Cathedral Road, indicating capacity and service…
- Syngene International (Q1 FY26)
Operating EBITDA grew 21% YoY in Q1 FY '26 with margins rising to ~24% from 22% last year. Key concall takeaways from Syngene International Ltd's Q1 FY26…
- Yatharth Hospital & Trauma Care Services (Q1 FY26)
International patient business is growing but will remain around 10% of revenue, positively impacting ARPOB without hurting margins. Key concall takeaways from…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Vijaya Diagnostic Centre Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vijaya Diagnostic Centre Ltd Q1 FY26 results?
Vijaya Diagnostic targets consistent revenue growth of 15%+ annually, backed by about 13% volume growth. The company maintains a consistent revenue growth guidance of 15%+ annually, driven primarily by volume growth (~13%) and price increases (1.5%-2%).
What is Vijaya Diagnostic Centre Ltd share price analysis?
Vijaya Diagnostic Centre Ltd currently shows a neutral. The stock trades at a P/E of 82.7 with a market cap of ₹14,313 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vijaya Diagnostic Centre Ltd planning capital expenditure?
For FY26, guided overall CAPEX for new centers is around Rs. 150-155 crores.
Keep Vijaya Diagnostic Centre Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
